Ocular drug development--future directions.

Abstract:

:Technology has caught up with retinal diseases of neovasculature. Work with anti-cancer, anti-angiogenic agents has fueled the way for ocular therapeutics. The market size for age-related macular degeneration and diabetic retinopathy is huge. Fifteen million people in the United States alone have age-related macular degeneration with 2 million new cases each year (1). About 20.8 million people in the United States have diabetes. Of those, 14.6 million are diagnosed and 6.2 million are undiagnosed (2). Of patients who have had type 1 diabetics for more than 20 years, 50% will have proliferative diabetic retinopathy (3). Between 60% and 80% of type 2 diabetics will manifest retinopathy after 15 years, and 20% will progress to proliferative retinopathy after 25 years of duration (4). Big pharma and biotech were complacent in developing drugs capable of having effect on ocular neovascular diseases even though technologies were available, at least on the research level, long before there was serious activity to bring such technologies to the clinic. Finally, over the last three years, triple digit million dollar business development deals have been consummated, mostly for VEGF-A targeted modalities. Such biodollar partnerships were the eye openers which have now led to a concerted action to develop ocular drugs to combat ocular neovascularization. Anti-VEGF-A technologies do not constitute the whole story. Agents with broader activity, activity that occurs later down the angiogenic pathway and those drugs which are capable to synergize with anti-VEGF-A technologies will dominate the next wave in ocular diseases of neovascularization and will lead the next round of significant business development deals.

journal_name

Angiogenesis

journal_title

Angiogenesis

authors

Sherris D

doi

10.1007/s10456-007-9068-y

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

71-6

issue

2

eissn

0969-6970

issn

1573-7209

journal_volume

10

pub_type

杂志文章
  • Genetic markers of bevacizumab-induced hypertension.

    abstract:PURPOSE:There are currently no validated biomarkers predicting bevacizumab treatment outcome or toxicity. We combined biomarker data from six phase III trials of bevacizumab to assess whether genetic variation in vascular endothelial growth factor-A (VEGF-A) pathway or hypertension-related genes are associated with bev...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-014-9424-7

    authors: Lambrechts D,Moisse M,Delmar P,Miles DW,Leighl N,Escudier B,Van Cutsem E,Bansal AT,Carmeliet P,Scherer SJ,de Haas S,Pallaud C

    更新日期:2014-07-01 00:00:00

  • Protein kinase D2 and heat shock protein 90 beta are required for BCL6-associated zinc finger protein mRNA stabilization induced by vascular endothelial growth factor-A.

    abstract::Vascular endothelial growth factor (VEGF) is a major angiogenic factor that activates pro-angiogenic molecules to generate new vessels. Recently, we identified a VEGF-A-induced pro-angiogenic gene, BCL-6 associated zinc finger protein (BAZF), in endothelial cells. BAZF interacts with CBF1, a transcriptional regulator ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-013-9345-x

    authors: Miwa D,Sakaue T,Inoue H,Takemori N,Kurokawa M,Fukuda S,Omi K,Goishi K,Higashiyama S

    更新日期:2013-07-01 00:00:00

  • Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-maf.

    abstract::Angiogenesis is a complex process involving coordinated steps of endothelial cell activation, proliferation, migration, tube formation and capillary sprouting with participation of intracellular signaling pathways. Regulation of angiogenesis carries tremendous potential for cancer therapy. Our earlier studies showed t...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-005-9024-7

    authors: Kalkunte S,Brard L,Granai CO,Swamy N

    更新日期:2005-01-01 00:00:00

  • Arterial endoglin does not protect against arteriovenous malformations.

    abstract:INTRODUCTION:Endoglin (ENG) forms a receptor complex with ALK1 in endothelial cells (ECs) to promote BMP9/10 signalling. Loss of function mutations in either ENG or ALK1 genes lead to the inherited vascular disorder hereditary haemorrhagic telangiectasia (HHT), characterised by arteriovenous malformations (AVMs). Howev...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-020-09731-z

    authors: Singh E,Redgrave RE,Phillips HM,Arthur HM

    更新日期:2020-11-01 00:00:00

  • miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells.

    abstract::The sprouting of endothelial cells is the first step of tumor angiogenesis. Our previous study suggests that miR-153 suppresses breast tumor angiogenesis partially through targeting hypoxia-induced factor (HIF1α). In this study, we demonstrated that miR-153 also suppresses the migration and the tube formation of endot...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-018-9630-9

    authors: Liang H,Ge F,Xu Y,Xiao J,Zhou Z,Liu R,Chen C

    更新日期:2018-11-01 00:00:00

  • VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities.

    abstract:BACKGROUND:Angiogenesis plays a pivotal role in neoplastic growth and metastasis formation. Vascular endothelial growth factor A (VEGFA) is a major player in physiological and tumour-induced angiogenesis and numerous human tumours have been show to overexpress VEGFA. Moreover increased VEGFA gene expression has been fo...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-013-9396-z

    authors: Andreozzi M,Quagliata L,Gsponer JR,Ruiz C,Vuaroqueaux V,Eppenberger-Castori S,Tornillo L,Terracciano LM

    更新日期:2014-07-01 00:00:00

  • Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions.

    abstract::Molecular imaging agents are extending the potential of noninvasive medical diagnosis from basic gross anatomical descriptions to complicated phenotypic characterizations based upon the recognition of unique cell-surface biochemical signatures. Although originally the purview of nuclear medicine, "molecular imaging" i...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-010-9166-0

    authors: Lanza GM,Winter PM,Caruthers SD,Hughes MS,Hu G,Schmieder AH,Wickline SA

    更新日期:2010-06-01 00:00:00

  • Piwi-interacting RNAs (piRNAs) as potential biomarkers and therapeutic targets for cardiovascular diseases.

    abstract::Cardiovascular diseases (CVDs) are the leading causes of death worldwide. Increasing reports demonstrated that non-coding RNAs (ncRNAs) have been crucially involved in the development of CVDs. Piwi-interacting RNAs (piRNAs) are a novel cluster of small non-coding RNAs with strong uracil bias at the 5' end and 2'-O-met...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-020-09750-w

    authors: Li M,Yang Y,Wang Z,Zong T,Fu X,Aung LHH,Wang K,Wang JX,Yu T

    更新日期:2020-10-04 00:00:00

  • PDGFRβ-P2A-CreERT2 mice: a genetic tool to target pericytes in angiogenesis.

    abstract::Pericytes are essential mural cells distinguished by their association with small caliber blood vessels and the presence of a basement membrane shared with endothelial cells. Pericyte interaction with the endothelium plays an important role in angiogenesis; however, very few tools are currently available that allow fo...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-017-9570-9

    authors: Cuervo H,Pereira B,Nadeem T,Lin M,Lee F,Kitajewski J,Lin CS

    更新日期:2017-11-01 00:00:00

  • Inhibition of B16 melanoma growth in vivo by retroviral vector-mediated human ribonuclease inhibitor.

    abstract::Human ribonuclease inhibitor (hRI) can inhibit angiogenesis by reversibly binding angiogenin, a member of the RNaseA superfamily, and by suppressing the expression of basic fibroblast growth factor (bFGF). Angiogenesis is necessary for the growth and metastasis of tumors. To study the links between hRI, angiogenesis, ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-005-5714-4

    authors: Wang T,Yang M,Chen J,Watkins T,Xiuyun C

    更新日期:2005-01-01 00:00:00

  • Oxidized phospholipids stimulate production of stem cell factor via NRF2-dependent mechanisms.

    abstract::Receptor tyrosine kinase c-Kit and its ligand stem cell factor (SCF) regulate resident vascular wall cells and recruit circulating progenitors. We tested whether SCF may be induced by oxidized palmitoyl-arachidonoyl-phosphatidylcholine (OxPAPC) known to accumulate in atherosclerotic vessels. Gene expression analysis d...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-017-9590-5

    authors: Afonyushkin T,Oskolkova OV,Bochkov VN

    更新日期:2018-05-01 00:00:00

  • In vivo malignant phenotype of hst-1-transfected cells regulated by paracrine endothelial cell growth stimulation by HST-1.

    abstract::The hst-1 gene product, one of the fibroblast growth factor family proteins, has transforming and angiogenic activities. The BALB/c 3T3 cell line was transfected with an expression vector harboring human hst-1 cDNA and the malignant properties of two stably transfected clones, TC-1 and TC-2, were examined. The stimula...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1009288405970

    authors: Aonuma M,Murakami K,Hirotani K,Horiuchi T,Sakamoto H,Terada M,Tanaka NG

    更新日期:1998-01-01 00:00:00

  • Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.

    abstract:BACKGROUND:In patients with resectable colorectal liver metastases (CRLM), distinct histopathological growth patterns (HGPs) develop at the interface between the tumour and surrounding tissue. The desmoplastic (d) HGP is characterised by angiogenesis and a peripheral fibrotic rim, whereas non-angiogenic HGPs co-opt end...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-019-09661-5

    authors: Galjart B,Nierop PMH,van der Stok EP,van den Braak RRJC,Höppener DJ,Daelemans S,Dirix LY,Verhoef C,Vermeulen PB,Grünhagen DJ

    更新日期:2019-05-01 00:00:00

  • The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.

    abstract::Although monotherapy with angiostatic drugs is still far from effective, there is abundant evidence that angiostatic therapy can improve the efficacy of conventional treatments like radiotherapy. This has instigated numerous efforts to optimize and clinically implement the combination of angiostatic drugs with radiati...

    journal_title:Angiogenesis

    pub_type: 历史文章,杂志文章,评审

    doi:10.1007/s10456-017-9546-9

    authors: Hamming LC,Slotman BJ,Verheul HMW,Thijssen VL

    更新日期:2017-05-01 00:00:00

  • Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations.

    abstract:BACKGROUND:The term "intramuscular hemangioma capillary type" (IHCT) refers to a fast-flow vascular lesion that is classified as a tumor, although its phenotype overlaps with arteriovenous malformation (AVM). The purpose of this study was to identify somatic mutations in IHCT. METHODS:Affected tissue specimens were ob...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-019-09678-w

    authors: Goss JA,Konczyk DJ,Smits PJ,Kozakewich HPW,Alomari AI,Al-Ibraheemi A,Taghinia AH,Dickie BH,Adams DM,Fishman SJ,Mulliken JB,Warman ML,Greene AK

    更新日期:2019-11-01 00:00:00

  • Plants and their active compounds: natural molecules to target angiogenesis.

    abstract::Angiogenesis, or new blood vessel formation, is an important process in the pathogenesis of several diseases and thus has been targeted for the prevention and treatment for many disorders. However, the anti-angiogenic agents that are currently in use are mainly synthetic compounds and humanized monoclonal antibodies, ...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-016-9512-y

    authors: Lu K,Bhat M,Basu S

    更新日期:2016-07-01 00:00:00

  • KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.

    abstract::Kaposi's sarcoma (KS) is a vascular neoplasm caused by infection of endothelial or endothelial precursor cells with the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8). Research efforts have focused on defining the molecular events explaining how KSHV promotes pathological angiogenesis and KS tumor formation. mTOR...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-015-9475-4

    authors: Ma T,Patel H,Babapoor-Farrokhran S,Franklin R,Semenza GL,Sodhi A,Montaner S

    更新日期:2015-10-01 00:00:00

  • Endothelial cells expressing low levels of CD143 (ACE) exhibit enhanced sprouting and potency in relieving tissue ischemia.

    abstract::The sprouting of endothelial cells from pre-existing blood vessels represents a critical event in the angiogenesis cascade. However, only a fraction of cultured or transplanted endothelial cells form new vessels. Moreover, it is unclear whether this results from a stochastic process or instead relates to certain endot...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-014-9414-9

    authors: Silva EA,Eseonu C,Mooney DJ

    更新日期:2014-07-01 00:00:00

  • Time-dependent LXR/RXR pathway modulation characterizes capillary remodeling in inflammatory corneal neovascularization.

    abstract::Inflammation in the normally immune-privileged cornea can initiate a pathologic angiogenic response causing vision-threatening corneal neovascularization. Inflammatory pathways, however, are numerous, complex and are activated in a time-dependent manner. Effective resolution of inflammation and associated angiogenesis...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-018-9604-y

    authors: Mukwaya A,Lennikov A,Xeroudaki M,Mirabelli P,Lachota M,Jensen L,Peebo B,Lagali N

    更新日期:2018-05-01 00:00:00

  • Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress.

    abstract::Altered RNA processing is an underlying mechanism of amyotrophic lateral sclerosis (ALS). Missense mutations in a number of genes involved in RNA function and metabolisms are associated with ALS. Among these genes is angiogenin (ANG), the fifth member of the vertebrate-specific, secreted ribonuclease superfamily. ANG ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-012-9322-9

    authors: Li S,Sheng J,Hu JK,Yu W,Kishikawa H,Hu MG,Shima K,Wu D,Xu Z,Xin W,Sims KB,Landers JE,Brown RH Jr,Hu GF

    更新日期:2013-04-01 00:00:00

  • Contrasting effects of sunitinib within in vivo models of metastasis.

    abstract::Sunitinib is a potent and clinically approved tyrosine kinase inhibitor that can suppress tumour growth by inhibiting angiogenesis. However, conflicting data exist regarding the effects of this drug on the growth of metastases in preclinical models. Here we use 4T1 and RENCA tumour cells, which both form lung metastas...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-012-9291-z

    authors: Welti JC,Powles T,Foo S,Gourlaouen M,Preece N,Foster J,Frentzas S,Bird D,Sharpe K,van Weverwijk A,Robertson D,Soffe J,Erler JT,Pili R,Springer CJ,Mather SJ,Reynolds AR

    更新日期:2012-12-01 00:00:00

  • Models and molecular mechanisms of blood vessel co-option by cancer cells.

    abstract::Cancer cells have diverse mechanisms for utilizing the vasculature; they can initiate the formation of new blood vessels from preexisting ones (sprouting angiogenesis) or they can form cohesive interactions with the abluminal surface of preexisting vasculature in the absence of sprouting (co-option). The later process...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-019-09684-y

    authors: Zhang Y,Wang S,Dudley AC

    更新日期:2020-02-01 00:00:00

  • Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety.

    abstract::Retinopathy of prematurity (ROP) with pathological retinal neovascularization is the most common cause of blindness in children. ROP is currently treated with laser therapy or cryotherapy, both of which may adversely affect the peripheral vision with limited efficacy. Owing to the susceptibility of the developing reti...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-019-09662-4

    authors: Tang F,LeBlanc ME,Wang W,Liang D,Chen P,Chou TH,Tian H,Li W

    更新日期:2019-08-01 00:00:00

  • CLT1 targets angiogenic endothelium through CLIC1 and fibronectin.

    abstract::Angiogenesis is important for tumor growth and metastasis. CLT1 (CGLIIQKNEC), a peptide that binds to tumor interstitial spaces in the presence of fibrin-fibronectin, has structural similarity to the anti-angiogenic β-sheet peptides anastellin and anginex. This similarity is reflected in the ability of CLT1 to form co...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-011-9247-8

    authors: Knowles LM,Malik G,Hood BL,Conrads TP,Pilch J

    更新日期:2012-03-01 00:00:00

  • Angiogenesis and chronic inflammation: cause or consequence?

    abstract::Evidence has been gathered regarding the association between angiogenesis and inflammation in pathological situations. These two phenomena have long been coupled together in many chronic inflammatory disorders with distinct etiopathogenic origin, including psoriasis, rheumatoid arthritis, Crohn's disease, diabetes, an...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-007-9074-0

    authors: Costa C,Incio J,Soares R

    更新日期:2007-01-01 00:00:00

  • Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris.

    abstract::Although we reported that basic fibroblast growth factor (bFGF) levels in pericardial fluid of patients with unstable angina are apparently increased, it was unclear whether vascular endothelial growth factor (VEGF) is also increased in patients with myocardial ischemia. Using an enzyme-linked immunosorbent assay, we ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1009062712441

    authors: Fujita M,Ikemoto M,Tanaka T,Tamaki S,Yamazato A,Sawamura T,Hasegawa K,Kihara Y,Nohara R,Sasayama S

    更新日期:1998-01-01 00:00:00

  • Visualization of endothelial cell cycle dynamics in mouse using the Flt-1/eGFP-anillin system.

    abstract::Endothelial cell proliferation is a key process during vascular growth but its kinetics could only be assessed in vitro or ex vivo so far. To enable the monitoring and quantification of cell cycle kinetics in vivo, we have generated transgenic mice expressing an eGFP-anillin construct under control of the endothelial-...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-018-9601-1

    authors: Herz K,Becker A,Shi C,Ema M,Takahashi S,Potente M,Hesse M,Fleischmann BK,Wenzel D

    更新日期:2018-05-01 00:00:00

  • STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.

    abstract::A missense mutation from arginine to tryptophan at residue 849 in the kinase domain of Tie2 (Tie2-R849W) is commonly identified in familial venous malformations. The mechanistic action of Tie2-R849W variant expression on angiogenic cascades including smooth muscle cell recruitment, however, remains elusive. To avoid c...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-012-9313-x

    authors: Huang YH,Wu MP,Pan SC,Su WC,Chen YW,Wu LW

    更新日期:2013-01-01 00:00:00

  • Thymosin beta4 enhances endothelial cell differentiation and angiogenesis.

    abstract::When human umbilical vein endothelial cells (HUVEC) differentiate into capillary-like tubes, there is a five-fold upregulation of the mRNA for thymosin beta4 (Tbeta4) (Grant et al. J Cell Sci 1995; 108: 3685-94 [1]) and this endogenous expression plays an important role in endothelial cell attachment to and spreading ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1009041911493

    authors: Grant DS,Rose W,Yaen C,Goldstein A,Martinez J,Kleinman H

    更新日期:1999-01-01 00:00:00

  • Differential gene expression analysis of tubule forming and non-tubule forming endothelial cells: CDC42GAP as a counter-regulator in tubule formation.

    abstract::The formation of new tubular structures from a quiescent endothelial lining is one of the hallmarks of sprouting angiogenesis. This process can be mimicked in vitro by inducing capillary-like tubular structures in a three-dimensional (3D) fibrin matrix. We aimed to analyze the differential mRNA expression in two pheno...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-007-9086-9

    authors: Engelse MA,Laurens N,Verloop RE,Koolwijk P,van Hinsbergh VW

    更新日期:2008-01-01 00:00:00